M I Sánchez-Lorencio1, P Ramirez2, L Saenz3, M V Martínez Sánchez4, V De La Orden5, B Mediero-Valeros5, S Veganzones-De-Castro5, A Baroja-Mazo6, B Revilla Nuin6, M R Gonzalez2, P A Cascales-Campos2, J A Noguera-Velasco1, A Minguela4, E Díaz-Rubio7, J A Pons8, P Parrilla2. 1. Clinical Analysis Department, Hospital Clínico Universitario Virgen de la Arrixaca-IMIB, Murcia, Spain. 2. Liver Transplant Unit, Department of Surgery, Hospital Clínico Universitario Virgen de la Arrixaca-IMIB, Murcia, Spain. 3. Navarre Unified Laboratory Department, Navarre Hospital Complex, Pamplona, Spain. Electronic address: txito3@hotmail.com. 4. Immunology Service, Hospital Clínico Universitario Virgen de la Arrixaca-IMIB, Murcia, Spain. 5. CTC Unit, Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain. 6. Experimental Surgery Unit, Hospital Clínico Universitario Virgen de la Arrixaca-IMIB, Murcia, Spain. 7. Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain. 8. Department of Hepatology, Hospital Clínico Universitario Virgen de la Arrixaca-IMIB, Murcia, Spain.
Abstract
INTRODUCTION: Orthotopic liver transplantation (OLT) is considered one of the few curative treatments available for early stages of hepatocellular carcinoma (HCC). It has been shown that more than 10% of transplanted individuals suffer relapse during the first year after surgery and most of them die because of the tumor. The circulating tumor cells (CTCs) are the main source of recurrences as they disseminate from a primary or metastatic tumor lesion through peripheral blood. We aimed to determine the concentration of CTCs in peripheral blood in these patients by 2 different approaches: the CellSearch and the IsoFlux systems to assess their applicability to this disease monitoring. PATIENTS AND METHODS: A comparative study was conducted in 21 patients with HCC eligible for liver transplantation according to the Milan criteria, whose peripheral blood was processed by the CellSearch and the IsoFlux systems. RESULTS: CTCs were isolated in 1 of the 21 patients (4.7%) by the CellSearch system and in 19 of the 21 patients (90.5%) by the IsoFlux method. The comparison of both methods using Bland-Altman plot shows that there is not consistency in the determination of CTCs in our patients, finding a proportional bias between them. CONCLUSION: The results obtained by both CTCs isolation systems are not interchangeable nor transferable. The CellSearch system does not seem to be the ideal approach for studying CTCs in patients with HCC. The IsoFlux system displays greater sensitivity in the identification of CTCs and might become an important tool in patient management.
INTRODUCTION: Orthotopic liver transplantation (OLT) is considered one of the few curative treatments available for early stages of hepatocellular carcinoma (HCC). It has been shown that more than 10% of transplanted individuals suffer relapse during the first year after surgery and most of them die because of the tumor. The circulating tumor cells (CTCs) are the main source of recurrences as they disseminate from a primary or metastatic tumor lesion through peripheral blood. We aimed to determine the concentration of CTCs in peripheral blood in these patients by 2 different approaches: the CellSearch and the IsoFlux systems to assess their applicability to this disease monitoring. PATIENTS AND METHODS: A comparative study was conducted in 21 patients with HCC eligible for liver transplantation according to the Milan criteria, whose peripheral blood was processed by the CellSearch and the IsoFlux systems. RESULTS: CTCs were isolated in 1 of the 21 patients (4.7%) by the CellSearch system and in 19 of the 21 patients (90.5%) by the IsoFlux method. The comparison of both methods using Bland-Altman plot shows that there is not consistency in the determination of CTCs in our patients, finding a proportional bias between them. CONCLUSION: The results obtained by both CTCs isolation systems are not interchangeable nor transferable. The CellSearch system does not seem to be the ideal approach for studying CTCs in patients with HCC. The IsoFlux system displays greater sensitivity in the identification of CTCs and might become an important tool in patient management.
Authors: Colin M Court; Shuang Hou; Paul Winograd; Nicholas H Segel; Qingyu Wilda Li; Yazhen Zhu; Saeed Sadeghi; Richard S Finn; Ekambaram Ganapathy; Min Song; Samuel W French; Bita V Naini; Shonan Sho; Fady M Kaldas; Ronald W Busuttil; James S Tomlinson; Hsian-Rong Tseng; Vatche G Agopian Journal: Liver Transpl Date: 2018-07 Impact factor: 5.799
Authors: Daniel Brungs; David Lynch; Alison Ws Luk; Elahe Minaei; Marie Ranson; Morteza Aghmesheh; Kara L Vine; Martin Carolan; Mouhannad Jaber; Paul de Souza; Therese M Becker Journal: World J Gastroenterol Date: 2018-02-21 Impact factor: 5.742
Authors: Joanna Budna-Tukan; Monika Świerczewska; Martine Mazel; Wojciech A Cieślikowski; Agnieszka Ida; Agnieszka Jankowiak; Andrzej Antczak; Michał Nowicki; Klaus Pantel; David Azria; Maciej Zabel; Catherine Alix-Panabières Journal: Cancers (Basel) Date: 2019-06-10 Impact factor: 6.639
Authors: María Lola Espejo-Cruz; Sandra González-Rubio; Javier Zamora-Olaya; Víctor Amado-Torres; Rafael Alejandre; Marina Sánchez-Frías; Rubén Ciria; Manuel De la Mata; Manuel Rodríguez-Perálvarez; Gustavo Ferrín Journal: Int J Mol Sci Date: 2021-12-03 Impact factor: 5.923
Authors: Víctor Amado; Sandra González-Rubio; Javier Zamora; Rafael Alejandre; María Lola Espejo-Cruz; Clara Linares; Marina Sánchez-Frías; Gema García-Jurado; José Luis Montero; Rubén Ciria; Manuel Rodríguez-Perálvarez; Gustavo Ferrín; Manuel De la Mata Journal: Cancers (Basel) Date: 2021-05-19 Impact factor: 6.639
Authors: Junhao Wu; Katharina Raba; Rosa Guglielmi; Bianca Behrens; Guus Van Dalum; Georg Flügen; Andreas Koch; Suraj Patel; Wolfram T Knoefel; Nikolas H Stoecklein; Rui P L Neves Journal: Cancers (Basel) Date: 2020-04-10 Impact factor: 6.639